The initiative aims to scale Aidoc’s AI clinical operating system (aiOS) across its nine hospitals and more than 250 care centers.
WellSpan Health, a leading healthcare system based in Pennsylvania, has announced plans to expand the use of clinical artificial intelligence (AI) technology across its network.
The initiative aims to scale Aidoc’s AI clinical operating system (aiOS) across its nine hospitals and more than 250 care centers.
In parallel, WellSpan will also activate 21 additional AI-powered care pathways across seven service lines, which is expected to improve clinical decision support in more specialties beyond radiology.
The initiative follows the initial deployment of the AI platform, which demonstrated measurable value in identifying critical findings and accelerating urgent diagnoses.
Last year, Aidoc analyzed more than 200,000 patient cases in WellSpan, flagging more than 10,000 potentially critical findings, including pulmonary embolisms, brain hemorrhages, and vessel occlusions.
This expansion has reportedly reduced bottlenecks in urgent diagnostic workflows and unlocked measurable improvements in response time by accelerating high-quality, standardized care across the network.
Commenting on the new initiative, Roxanna Gapstur, president and CEO of WellSpan, said: “Aidoc has increased the expertise of our radiologists to achieve greater quality and safety, greater accuracy and a better work experience, especially important amid the current physician shortage. Now, with this expansion, patients across the WellSpan system will be able to benefit, experiencing faster, more accurate diagnoses and better health outcomes.”
Under the new expansion strategy, the iOS platform will be fully integrated with WellSpan’s imaging and electronic medical records (EMR) environments, which seek to support seamless workflows that connect multiple departments and care teams.
The new solutions are designed to expand clinical coverage, supporting care teams in flagged conditions such as aortic dissection, free air in the abdomen and pelvis, pneumothorax, rib fractures and more, while expanding AI support across all service lines, including cardiology, vascular surgery and neuroscience.
Additionally, the launch integrates third-party clinical AI tools within the iOS platform to support the detection of lung nodules and breast lesions.
By extending Aidoc’s iOS across specialties, WellSpan aims to integrate a unified intelligence layer into everyday workflows that is expected to improve care efficiency, physician satisfaction and reduce burnout.
These capabilities support automated referral of patients with flagged findings to appropriate care teams, which is expected to streamline care coordination, ensure timely intervention, and support long-term patient outcomes.
Reflecting on his thoughts on the new partnership, Elad Walach, co-founder and CEO of Aidoc, said: “WellSpan has dominated the change management and clinical AI adoption movement. By extending Aidoc aiOS across specialties, WellSpan is bringing a unified layer of intelligence into everyday workflows that elevates care efficiency while improving physician satisfaction and reducing burnout. This is how health systems elevate clinical operations at scale.”
Stay tuned for more such updates on Digital Health News
